Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder characterized by tumors in parathyroids, enteropancreatic endocrine tissues, anterior pituitary, and other tissues. The gene for MEN1 has recently been cloned and shown to code for a 610-amino acid protein of enigmatic func
Screening of Patients with Multiple Endocrine Neoplasia Type 1 (MEN-1): A Critical Analysis of Its Value
β Scribed by Jens Waldmann; Volker Fendrich; Nils Habbe; Detlef K. Bartsch; Emily P. Slater; Peter H. Kann; Matthias Rothmund; Peter Langer
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 267 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0364-2313
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The gene responsible for multiple endocrine neoplasia type I (MEN-l) syndrome has been mapped to chromosome l lq13. It appears to function as a tumoursuppressor gene analogous to that for retinoblastoma and allelic losses involving the wild-type of the MEN-1 allele have been found in parathyroid and
Multiple endocrine neoplasia type 1 (MEN-1) is an autosomal dominant tumor syndrome associated with parathyroid, gastroenteropancreatic (GEP), and pituitary neoplasia. Gastrinoma and GEP malignancy are common life-threatening endocrine complications of MEN-1. An effective management strategy for the